Wild-type (senile) ATTR amyloidosis history and symptoms: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 19: | Line 19: | ||
<br /> | <br /> | ||
{| class="wikitable" | {| class="wikitable" | ||
! | ! colspan="2" |Symptoms | ||
|- | |- | ||
|Cardiovascular involvement | |Cardiovascular involvement |
Latest revision as of 15:24, 2 December 2019
Wild-type (senile) ATTR amyloidosis Microchapters |
Differentiating Wild-type (senile) ATTR amyloidosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wild-type (senile) ATTR amyloidosis history and symptoms On the Web |
American Roentgen Ray Society Images of Wild-type (senile) ATTR amyloidosis history and symptoms |
FDA on Wild-type (senile) ATTR amyloidosis history and symptoms |
CDC on Wild-type (senile) ATTR amyloidosis history and symptoms |
Wild-type (senile) ATTR amyloidosis history and symptoms in the news |
Blogs on Wild-type (senile) ATTR amyloidosis history and symptoms |
Risk calculators and risk factors for Wild-type (senile) ATTR amyloidosis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
History
- Coexistence of both cardiac and peripheral nervous system (PNS) involvement should always raise suspicion for ATTR-related amyloidosis.
Symptoms
The clinical manifestations of TTR-related amyloidosis (ATTR) are determined by
- The subtype of transthyretin (TTR) protein mutation
- Tissue distributio
- The amount of amyloid deposition.
Common symptoms of ATTR include:
Symptoms | |
---|---|
Cardiovascular involvement |
|
Neuropathic involvement |
|
Other manifestations |
|